FDA Drugs recall ·
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets… recall
- Recall number
- D-0594-2026
- Date
- (initiated May 27, 2026)
- Company / brand
- Ajanta Pharma USA Inc
400 Crossing Blvd Ste 102, Bridgewater, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 6,143 bottles
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Why was it recalled?
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: PA00805, expires: 01/31/2029
Distribution
U.S. Nationwide
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0594-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.